Ranibizumab ophthalmic and Sinequan
Determining the interaction of Ranibizumab ophthalmic and Sinequan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Sinequan (Doxepin Capsules)
- Ranibizumab ophthalmic-Sinequan (Doxepin Oral Concentrate)
- Ranibizumab ophthalmic-Sinex Long-Acting
- Ranibizumab ophthalmic-Sinex Nasal Spray
- Ranibizumab ophthalmic-Singulair
- Ranibizumab ophthalmic-Singulair (Montelukast Chewable Tablets)
- Sinequan-Ranitidine
- Sinequan-Ranitidine Capsule
- Sinequan-Ranitidine Hydrochloride
- Sinequan-Ranitidine Injection
- Sinequan-Ranitidine Suspension
- Sinequan-Ranitidine Syrup